Birchview Capital »

Apellis Pharmaceuticals shares owned by Birchview Capital

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Birchview Capital from 13F filings

Historical chart of Birchview Capital investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Birchview Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Birchview Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $685k 18k 38.04
2023-06-30 $1.1M 12k 91.10
2023-03-31 $792k 12k 66.00
2022-12-31 $621k 12k 51.75
2022-09-30 $820k 12k 68.33
2022-06-30 $543k 12k 45.25
2022-03-31 $610k 12k 50.83
2021-12-31 $567k 12k 47.25
2021-09-30 $396k 12k 33.00
2021-06-30 $506k 8.0k 63.25
2021-03-31 $343k 8.0k 42.88
2020-12-31 $458k 8.0k 57.25
2020-09-30 $241k 8.0k 30.13
2020-06-30 $261k 8.0k 32.63
2020-03-31 $214k 8.0k 26.75
2019-12-31 $245k 8.0k 30.62
2019-06-30 $203k 8.0k 25.38